22157.jpg
Global AI Trends in Pharmaceutical Manufacturing, 2023 Research Report
January 23, 2024 08:43 ET | Research and Markets
Dublin, Jan. 23, 2024 (GLOBE NEWSWIRE) -- The "Global AI trends in Pharmaceutical Manufacturing" report has been added to ResearchAndMarkets.com's offering. This report provides invaluable expert...
Global Cell and Gene Therapy CDMO Market
Global Cell and Gene Therapy CDMO Market Analysis Report 2023: A $2.54 Billion Industry in 2022 Growing with a CAGR of 30.75% During 2024-2029
January 08, 2024 12:53 ET | Research and Markets
Dublin, Jan. 08, 2024 (GLOBE NEWSWIRE) -- The "Global Cell and Gene Therapy CDMO Market: Analysis By Type, Application, Indication, By Region, By Country: Market Insights and Forecast" report has...
Societal Color Logo and Tagline.png
Societal CDMO Reports Inducement Grants for New Staff
January 05, 2024 16:05 ET | Societal CDMO, Inc.
SAN DIEGO and GAINESVILLE, Ga., Jan. 05, 2024 (GLOBE NEWSWIRE) -- Societal CDMO, Inc. (“Societal CDMO”; NASDAQ: SCTL), a contract development and manufacturing organization (CDMO) dedicated to...
PG LOGO 1200x628px.jpg
Polaris Group Announced the Acquisition of Genovior Biotech, Initiating Dual-Engine Growth
December 21, 2023 21:16 ET | Polaris Group
TAIPEI, Taiwan and SAN DIEGO, Dec. 21, 2023 (GLOBE NEWSWIRE) -- Polaris Group (The Company, TWSE:6550) announced that its board approved to increase the acquisition of Genovior Biotech's shares to...
Rentschler Biopharma logo from PR.jpg
Rentschler Biopharma Announces Major Client Project for New U.S. Facility at Milford, MA Site
December 20, 2023 07:00 ET | Rentschler Biopharma SE
State-of-the-art Rentschler Biopharma Manufacturing Center (RBMC) facility slated to open for business next year LAUPHEIM, Germany and MILFORD, Mass., Dec. 20, 2023 (GLOBE NEWSWIRE) -- Rentschler...
Intravacc logo.png
Intravacc launches new website with a wealth of scientific knowledge to elevate vaccine innovation
December 20, 2023 06:10 ET | Intravacc B.V.
Intravacc's new website offers an immersive user experience, showcasing their CDMO expertise vaccine platforms and a hub for scientific publications.
Avid Logo June 2022.jpg
Avid Bioservices Reports Financial Results for Second Quarter Ended October 31, 2023
December 07, 2023 16:05 ET | Avid Bioservices, Inc
-- Recorded Second Quarter Revenue of $25.4 Million -- -- Signed $35 Million in Net New Business Orders Resulting in a Backlog of $199 Million -- -- Entered into Partnership with California...
Rentschler Biopharma logo from PR.jpg
Rentschler Biopharma SE appoints Gunnar Voss von Dahlen as Chief Financial Officer and completes Executive Board
December 07, 2023 04:00 ET | Rentschler Biopharma SE
LAUPHEIM, Germany and MILFORD, Mass. and STEVENAGE, United Kingdom, Dec. 07, 2023 (GLOBE NEWSWIRE) -- Rentschler Biopharma SE, a leading contract development and manufacturing organization (CDMO)...
Global Recombinant Protein Therapeutics CDMO Market
Global Recombinant Protein Therapeutics CDMO Market Report 2023-2030: Market Set to Grow Driven by Rising Chronic Diseases, Advancements in Biotechnology Fuel Demand
December 06, 2023 09:53 ET | Research and Markets
Dublin, Dec. 06, 2023 (GLOBE NEWSWIRE) -- The "Recombinant Protein Therapeutics CDMO Market Size, Share & Trends Analysis Report By Type (Growth Hormones, Interferons, Vaccines,...
Asia-Pacific Nucleic Acid Therapeutics CDMO Market
Asia-Pacific Nucleic Acid Therapeutics CDMO Market Report 2023: Market to Reach $4.04 Billion by 2033 - Significant Number of Collaborations among Market Players
December 06, 2023 04:58 ET | Research and Markets
Dublin, Dec. 06, 2023 (GLOBE NEWSWIRE) -- The "Asia-Pacific Nucleic Acid Therapeutics CDMO Market - Analysis and Forecast, 2023-2033" report has been added to ResearchAndMarkets.com's offering.The...